Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 69Triple Negative Breast Neoplasms 8Carcinoma, Intraductal, Noninfiltrating 6Breast Carcinoma In Situ 4Unilateral Breast Neoplasms 1Transsexualism 1Social Isolation 1Recurrence 1Patient Satisfaction 1Pain, Postoperative 1Neoplasm Micrometastasis 1Margins of Excision 1Lymphedema 1Local Recurrence of Malignant Tumor of Breast 1Inflammatory Breast Neoplasms 1Gynecomastia 1Carcinoma, Ductal, Breast 1Carcinoma, Ductal 1COVID-19 1Breast Image Scale Index for Self Esteem Evaluation 1Breast Cancer Female 1BRCA1/2 Mutation 1Autoimmune Diseases 1Anisomastia 1Anatomic Stage IV Breast Cancer AJCC v8 1Anatomic Stage II Breast Cancer AJCC v8 1Amenorrhea 1

Interventions

Zoledronic Acid 1Trastuzumab 1Mastectomy, Segmental 1Mastectomy, Modified Radical 1Epirubicin 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Micrometastasis × Mastectomy, Segmental × Breast × Clear all
NCT00242203 2013-08-13

Evaluation of Chemotherapy Prior to Surgery With or Without Zometa for Women With Locally Advanced Breast Cancer

Washington University School of Medicine

Phase 2 Completed
120 enrolled
Breast

Breast Neoplasms, Neoplasm Micrometastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡